Abstract Acute inflammation plays an important role in brain damage following cerebral ischemia and reperfusion (I/R) injury. The present study employed a rat model of middle cerebral artery occlusion to explore the neuroprotective effects of tanshinone IIA (TSN), which is widely used in China for treating cerebrovascular and cardiovascular diseases. Rats were divided into a sham-operated group and I/R transiently occluded then reperfused groups. Some of the I/R animals were treated daily for 7 or 15 days with two different doses of TSN. After 15 days, triphenyl tetrazolium chloride staining revealed less unstained area indicating fewer lesions in the TSN-treated I/R group relative to the untreated corresponding I/R group. TSN treatment dramatically reduced infarct sizes and reduced content of high mobility group box 1 protein following I/R. Nuclear translocation of NFjB was also attenuated in I/R animals subsequently receiving TSN. Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling staining revealed more apoptosis in the I/R model group and this was reduced in the I/R animals treated with TSN for 15 days. Thus, TSN mitigates the severity of damage effected by I/R.
Introduction
As worldwide populations age, the incidence of human cerebrovascular diseases continues to increase, and ischemic cerebrovascular diseases accounts for 80 % of these [7] . The high incidence and significant mortality rates of ischemic cerebrovascular disease are risks to human health [21] . Consequently, much attention has been given to understanding pathological mechanisms of focal cerebral ischemia and on finding effective treatments [6, 8] . The traditional Chinese medicine Salvia miltiorrhiza is the dry root and rhizome of S. miltiorrhiza Bunge. The lipid soluble constituent of this root, tanshinone IIA, (TSN) is the most abundant active component in this root from which it can be extracted [38] . It has widespread pharmacological effects and has recently become a subject of much research [17, 45] . TSN effectively inhibits cell lipid peroxidation, prevents apoptosis and methyl guanine transferase activity [9] , and can reduce cerebral infarction area in I/R rats [42] . Tanshinone has been to protect against ischemic/reperfusion-induced brain damage and has been used to treat focal cerebral ischemia thereby mitigating consequent disruption of the blood brain barrier and edema [5, 11, 29, 36, 38] . Tanshinones also inhibit amyloid aggregation by amyloid-b peptide, disaggregate amyloid fibrils, and protect cultured cells. They have also been reported to be beneficial in treatment of several cardiovascular and pulmonary diseases [39, 40] .
This protective effect may be mediated by down-regulation of high mobility group box-1 (HMGB1) receptor for advanced glycation endproducts (RAGE), toll-like receptor 4 (TLR4), and nuclear factor-jB (NFjB) [36] , and with upregulation of BDNF expression [13] . HMGB1, which was originally characterized as a nuclear DNA-binding protein with a highly conserved structure in several species, participates in nucleosome formation and regulates gene transcription [30] . When cells are injured or become necrotic, HMGB1, which normally resides in nuclei, translocates to the cytoplasm and/or extracellular space [27, 34] . HMGB1 is a key cytokine that plays an extracellular role in cellular activation and proinflammatory responses [41] . The presence of extracellular HMGB1 has been proven in necrotic tissue damaged by trauma or ischemia, and HMGB1 has been identified in the active secretions of many types of cells, including activated immune cells [18] . HMGB1 been implicated in several inflammatory diseases [1, 16, 25, 27] and is released from ischemic brain tissue, and is elevated in serum from stroke patients [10, 15] . HMGB1 exerts its biological effects through interaction with its receptor, TLR-4. Activation of TLR-4 can then lead to activation of NFjB [20, 25, 31] which will further increase expression of leukocyte adhesion molecules and the production of proinflammatory mediators by hematopoietic and endothelial cells, thereby promoting inflammation and causing organ and cell damage [32] . This is in part mediated by furthering of the maturation and migration of immune cells leading to increased reactivity of TLR [19, 33] . NF-jB is an important transcription factor, and persistent activation of NF-jB makes neurons vulnerable to ischemic insult [4, 43] . In the non-activated state, NFjB and the inhibitor of jB, (IjB) are found as a covalently bound trimer in the cytoplasm. When cells are stimulated by physical or chemical factors, IjB phosphorylation and degradation occurs, which results in movement of activated NFjB p65 from the cytoplasm to the nucleus, where it acts as a transcription factor to promote the production of inflammatory factors and thereby expand the inflammatory response. IjB kinase (IKK) interacts with IjB-a and specifically phosphorylates IjB-a on site that trigger its degradation thereby effecting NF-jB activation. The functional IKK complex contains three subunits, designated IKKa, IKKb, and IKKc; each making an essential contribution to IjB phosphorylation. Elevated HMGB1 and NF-jB expression are involved in ischemia-evoked neuronal injury and death via a pro-inflammatory mechanism [36] . Collectively, the evidence suggests that HMGB1 associated with NFjB activation pathway plays an important role in injury processes incurred after stroke [26] . In view of the reported neuroprotective effect of TSN, we have evaluated the effect of ischemic followed by reperfusion on phosphorylation and nuclear translocation of HMGB1 and NFjB, and the potential of TSN to mitigate any changes observed. The relationship between NFjB, and the inhibitors of kappa Ba in their phosphorylated and unphosphorylated forms (IjBa, p-IjBa), and the IKK kinases IKKa/b and p-IKKa/b, was also explored. We have investigated the neuroprotective mechanism of TSN in order to provide a theoretical foundation for future research. The effects of TSN on rats with cerebral I/R injury following middle coronary artery occlusion have been studied by assessing the extent of phosphorylation and nuclear translocation of the HMGB1/NFjB signaling pathway.
Glial fibrillary acidic protein (GFAP) is an important cytoskeletal component of astrocytes, which are the most abundant population of glial cells in the central nervous system microenvironment. They are intimately associated with brain homeostasis and the maintenance of brain function. Astrocytes not only provide metabolic and trophic support for neurons, they also modulate levels of neurotransmitters and synthesize and release neurotrophic factors, thus playing an important role in neurogenesis [12, 28] . However when excessively activated, they are also capable of initiating inflammatory events. Shortly after brain ischemia injury, a series of imbalances occurs that leads to an increased number of reactive astrocytes [3] . In ischemia-reperfusion injury, delayed neuronal death is associated with apoptosis especially in the ischemic penumbra [2] . Therefore, in this work, we also evaluated astroglial activation using the GFAP assay and cell death using the TUNEL assay.
Materials and Methods

Animal Treatment
Healthy adult male Sprague-Dawley rats aged 2.2-2.6 months, weighing 220-240 g were provided by the medical experimental animal Center of Xiangya Medical School, Central South University. Humidity levels were maintained at 55 ± 5 %, and the rats were kept under a 12 h light-dark cycle at 22 ± 2°C. All animal procedures were performed in accordance with the Guidelines of the Chinese Society for Laboratory Animals Science. The rats were randomly divided into eight experimental groups (n = 8 each). In the sham group (henceforth referred to as 'control group'), animals were subjected to the same daily treatment with saline and the same surgical procedures as the group transiently occluded for 2 h then reperfused (henceforth referred to as the I/R group), but without filament fixation. In the MCAO groups, the animals received a single I/R injury at the beginning of the study followed by an intraperitoneal (i.p.) injection of vehicle (phosphate-buffered saline, PBS). In the TSN IIA groups, the animals were treated as the I/R group but also received TSN IIA (5 or 10 mg/kg dissolved in saline and administered i.p.) immediately after surgery. Animals were sacrificed after 7 or 15 days, and the brains were removed for histology, immunohistochemistry, and western blotting.
Ischemia-Reperfusion Surgery
Induction of ischemia followed by reperfusion (I/R) was carried out as previously described [14] . Briefly, rats were anesthetized with 10 % chloral hydrate (350 ml/kg), and an incision was made in the midline of the neck. Then, the right common carotid artery and branches of the external carotid artery were ligated with a 4-0 filament (Beijing Shadong Biology Company, Beijing, China). The diameter of the filament is 0.26 mm, but the diameter of the tip is 0.34 mm to create a globular stopper that was introduced into the internal carotid artery and inserted until it meets resistance. The filament was then fixed and removed after 2 h. Rats in the control group underwent the same surgical procedure without the introduction of the filament into the internal carotid artery. Rectal temperatures were recorded and maintained at 37°C throughout the procedure. The standard of judging successful I/R is that upon recovery from anesthesia, the rats appear to have left-sided paralysis, difficulty standing, and circle to one side when held by the tail. Neurological function was scored using Longa and Bederson's 5-point scale within 24 h after recovery from anesthetic. The scoring is performed as follows: 0, no symptoms of neurological damage; 1, cannot fully extend front paws on opposite side; 2, resistance to the opposite side drops; 3, circles to the opposite side; 4, cannot spontaneously walk, loses consciousness.
Brain Sample Preparation
At 7 or 15 days after surgery, rats were deeply anesthetized with 10 % chloral hydrate (350 ml/kg), and the heart was exposed to perfuse PBS through the left ventricle. Next, PBS was changed to 4 % paraformaldehyde (PFA) and perfusion continued at 10 ml/min. Brain tissue was then collected and fixed in 4 % PFA at 4°C overnight, then transferred into 0.02 % sodium azide at 4°C and stored until use. Some tissue was rinsed with PBS, dehydrated in a graded ethanol series, embedded in paraffin, and coronally sectioned at 5 lm. The tissue slices were stored at 4°C before Eosin & Hematoxylin being stained. For 2,3,5-triphenyltetrazolium chloride (TTC) staining [37] , fresh brain slices were cut and placed in 2 % TTC solution for 30 min. Infarcted areas appeared as unstained tissue while normal brain tissues stained red.
Immunohistochemistry
Dewaxed sections were immersed in antigen retrieval solution (Vector Lab, Burlingame, CA, USA) for 20 min [44] and endogenous peroxidase was blocked by incubation in 3 % H 2 O 2 , and nonspecific background staining was blocked by incubating in 2 % bovine serum albumin (BSA). Sections were then incubated overnight with primary antibodies raised against HMGB1 (1:500; Abcam, Cambridge, UK) and NFjB (1:200; Cell Signaling Technology, Beverly, MA, USA). The sections were then incubated with secondary antibodies and ABC reagent (Vector Laboratories, Burlinghame, CA, USA). Finally, the sections were incubated for approximately 2-5 min with 3,3 0 -diaminobenzidine (Vector), dehydrated in a series of graded ethanols and xylene, then coverslipped with DePeX (Biomedical Specialties, Santa Monica, CA, USA).
Western Blotting
Tissue was homogenized in 10 volumes of Tris-buffered saline (TBS; 20 mM Tris-HCl, pH 7.4 and 150 mM NaCl) containing a cocktail of protease inhibitors (Sigma-Aldrich, St. Louis, MO, USA) [44] . Samples were electrophoretically separated with sodium dodecyl sulfate-polyacrylamide gel electrophoresis then transferred to polyvinylidene fluoride membranes, which were subsequently blocked with 5 % skim milk and then incubated primary in antibodies (HMGB1, from Abcam; NFjB-p65, p-NFjB from Cell Signaling Technology); IjB-a, p-IKB-a, IKKa/b, p-IKKa/b from Santa Cruz Biotechnology (Santa Cruz, CA, USA); and GFAP from Dako (Carpenteria, CA, USA), overnight at 4°C. The next day, blots were incubated with the corresponding horseradish peroxidase-labeled secondary antibodies (1:2,000). Labeling was detected using an enhanced chemiluminescence system (Amersham Biosciences, Piscataway, NJ, USA). The blots were subsequently re-probed with antibodies to assess equal loading (actin from Sigma and b-tubulin from Santa Cruz) following the same procedures as above. Bands were analyzed using densitometric software (Scion Corp., Frederick, MD, USA) and statistically analyzed with one-way analysis of variance (ANOVA). Analysis of these bands was from at least three separate experiments performed on different days.
TUNEL Staining
After the sections were treated with proteinase K (Sigma, St. Louis, MO, USA), they were subsequently incubated in dUTPdigoxin mixture followed by anti-DIG-anti-alkaline phosphatase solution. Sections were next treated in nitroblue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate (Roche, Nutley, NJ, USA) for color development. Finally, the slides were mounted with water-soluble mounting medium (Vector).
Image Acquisition
Immunostaining was quantitated using a Nikon Eclipse 80i microscope (Tokyo, Japan), and images were taken of the cortex and hippocampus with a high-resolution Nikon DS digital color camera. Rather than attempting subjective judgment of where effects were most pronounced, the use of whole cortical or hippocampal sections also allowed greater consistency for quantitation.
Statistical Analysis
The percentage of immunopositive area (immunopositive area/total image area 9 100) was determined for all of the markers by averaging 4-5 images per section that covered most of the regions using NIS-Elements AR 3.0 software (Nikon). Statistical significance was determined by oneway ANOVA. In all cases, differences were considered significant if P \ 0.05 (two-tailed).
Reagents
Tanshinone ( A terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) assay kit used for detection of apoptosis was from Roche (Indianapolis, IN, 
Results
Tanshinone IIA, TSN Reduces Brain Infarction Area in I/R
The control groups had normal brain tissue structure, whereas the I/R groups revealed ischemic changes in the infarcted areas as judged by an increase in unstained areas (Fig. 1a) . In animals treated with TSN, there were different degrees of reduction in brain infarction area. Quantitation of these results showed the most pathology in the I/R group without TSN treatment (Fig. 1b) . Pathological changes were partly but not completely reversed by TSN treatment, the reduction being greatest and significant only in the high-dosage group treated for 15 days.
TSN Suppresses the Increase in HMGB1 Protein
Occurring After Ischemic Injury HMGB1 was measured in brain tissue by immunohistochemistry and quantitated by Western blotting. I/R injury markedly increased levels of this protein which remained above control values (Fig. 2a) . Only the 15 days high-dose TSN significantly decreased this elevation of HMGB1. Quantitation of the corresponding Western blots revealed that this decrease effected by TSN was apparent in both the corresponding cytoplasmic and nuclear fractions (Fig. 2b) .
TSN IIA Suppresses the Increase in NFjB Occurring After Ischemic Injury
NFjB was quantitated by immunohistochemistry (Fig. 3a, b) and by analysis of Western blots (Fig. 3c) . Both assays showed I/R to enhance NFjB levels. This was reduced by TSN only in the nuclear fraction and only at the longest duration of exposure and highest dose used. This suggests that the migration of active NFjB into the nucleus was impaired by TSN.
Western blotting of cytoplasmic and nuclear fractions allowed distinction between NFjB and its activated phosphorylated form, pNFjB. Compared to I/R injury alone, the longer period (15 days) and higher dose of TSN dosing led to elevation of the proportion of NFjB present in the phosphorylated form in cytoplasm, but to depression of pNFjB in the nucleus (Fig. 3d) . Ischemia and reperfusion (I/R) treatment led to a significant increase in cytoplasmic IjBa and -IKKa/b at 7 or 15 days post-injury, but there changes attributable to subsequent TSN treatment were limited to partial reduction of IKKa/b after the shorter period of TSN treatment (Fig. 4a) . I/R did not alter cytoplasmic content of the de-activated phosphorylated inhibitors of NFjB, p-IjB and p-IKKa/b. However, both of these were greatly increased by the higher dose of TSN (Fig. 4b) . These changes were not, however, reflected in the corresponding nuclear levels of either native NFjB inhibitors or their phosphorylated derivatives all of which were unaltered by any treatment (data not shown).
TSN IIA Attenuates GFAP Expression After I/R Glial fibrillary acidic protein (GFAP) expression was raised several fold in I/R animals after 7 and 15 days, and treatment with the higher dose of TSN reduced this significantly ( Fig. 5) . This further suggests that the neuroprotective effects of TSH may primarily be based on its anti-inflammatory properties.
TSN Reduces I/R Induced Apoptosis in the Cortex and Hippocampus
Terminal deoxynucleotidyl transferase-mediated dUTPbiotin nick end labeling (TUNEL) staining revealed apoptotic nuclei in brain tissue from all groups except the controls (Fig. 6 ). The number of apoptotic cells was increased in the ischemic penumbrae and focal ischemic areas in all experimental groups. The intensity of TUNEL staining decreased over time. The extent of apoptosis was significantly further decreased after 15 days of treatment with the higher dose of TSN. In this case, both the size of the infarction area and number of apoptotic cells were strongly reduced. These findings imply that TSN treatment effectively attenuated I/R-induced apoptosis.
Discussion
The overall value of TSN treatment was indicated by its ability to lead to a decreased infarct area after I/R. Downregulation of HMGB1-induced NFjB activation might be a potential mechanism accounting for TSN's neuroprotective effects following cerebral ischemia. TSN also significantly reduced the effect of I/R in elevating GFAP levels, and this inhibition of astroglial activation may also be related to the protective effects of TSN in the ischemic region. Apoptosis occurred in frontal cortex and hippocampus of I/R groups. Apoptosis occurred as a time-dependent dynamic process, the number of apoptotic cells decreasing in 15 days I/R rats. The higher dose of TSN applied for 15 days further reduced the extent of apoptosis (Fig. 6) .
The primary mechanism underlying the cerebral protective effect of TSN IIA has not yet been clearly pinpointed. In addition to the pathways suggested by the current study, inhibition of calcium influx, antioxidant effects, and improved Na?, K?-ATPase function have all been suggested as primary mechanisms [39] . However, the current results suggest that an upstream event inhibited by TSN, is the inhibition of the injury-provoked translocation of HMGB1 to the nucleus. This may lead to the observed inhibition of nuclear migration of both NFjB and pNFjB, and initiate the anti-inflammatory properties of TSN. The increased phosphorylation of nuclear IjBa, and IKKa/b effected by TSN which implies inactivation of NFjB inhibitors, is difficult to account for. It may be that this apparently pro-inflammatory change is overwhelmed by the multiple anti-inflammatory effects of TSN.
Since ischemically damaged brains of patients show several pathological features that mimic Alzheimer-type dementia [22, 23] , TSN may also have applicability to this disorder. TSN has been reported to be protective against apoptic neurotoxicity induced by b-amyloid protein [24] and to inhibit amyloid fibril formation [35] .
In conclusion, TSN reduced brain infarct area in the ischemic hemisphere. TSN effectively attenuates the inflammatory response and apoptosis following I/R injury in rats. Reducing nuclear HMGB1, NFkB by retarding their translocation from cytoplasm may inhibit inflammatory gene activation and consequently reduce the production of inflammatory cytokines. Collectively, these results illustrate the value of this traditional Chinese medicine approach for treating cerebral I/R injury. The fact that TSN can significantly reduce pathological changes following I/R has implications for the clinical treatment of cerebral injury following ischemia. 
